Back to top

Citi Keeps Their Hold Rating on Tandem Diabetes Care (TNDM)

In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Tandem Diabetes Care, with a price target of $17.00. Wuensch cover...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tandem Diabetes Care, Inc. (TNDM)